ArticleScientific reports2025
Integrated multi omics and machine learning reveal mitochondrial immunometabolic networks in sepsis associated encephalopathy.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Identification of immune cell mitochondrial dysfunction characteristics and clinical predictive biomarkers in sepsis via multi-cohort machine learning and single-cell RNA sequencing.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026Article
- Mitochondrial Immunometabolism in Sepsis: From Oxidative Stress and mtDAMP Signaling to Biomarker-Guided Therapy.International journal of molecular sciences · 2026Review
- Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy.International journal of molecular sciences · 2026Review
- Metabolic reprogramming in sepsis-associated encephalopathy: emerging mechanisms, candidate biomarkers, and future therapeutic directions.Frontiers in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Sepsis-associated encephalopathy (SAE) is a major complication in intensive care units, characterized by diffuse brain dysfunction due to systemic inflammation. Despite advances in critical care medicine, SAE remains a key factor in poor patient outcomes, with its pathogenesis closely related to mitochondrial damage and the release of mitochondrial DNA (mtDNA). In this study, we integrated multiple transcriptomic and single-cell sequencing datasets to comprehensively analyze mitochondrial-associated differentially expressed genes (MitoDEGs) in SAE brain tissues. Using machine learning algorithms, we identified three core biomarkers (ALDH7A1, HOGA1, and AA467197). Functional enrichment analysis showed that the upregulated genes in SAE were mainly involved in immune and inflammatory responses, while the downregulated genes were associated with mitochondrial metabolism and vascular functions. Based on MitoDEGs, clinical subtype analysis shows that changes in mitochondrial function can effectively distinguish three sepsis subtypes (Cluster 1-3). Among these, Cluster 3 had worse prognosis due to enhanced mitochondrial function and activated inflammatory pathways. Immune microenvironment analysis revealed that MitoDEGs were closely associated with damage-associated molecular patterns (DAMPs) signaling and the expression of mitochondrial respiratory chain complexes. Experimental validation showed that exogenous mtDNA significantly increased the levels of inflammatory cytokines (TNF-α, IL-1β, and IL-6), thereby aggravating brain tissue pathological damage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.